Your browser doesn't support javascript.
loading
Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy.
Blazkova, Jana; Chun, Tae-Wook; Belay, Bietel W; Murray, Danielle; Justement, J Shawn; Funk, Emily K; Nelson, Amy; Hallahan, Claire W; Moir, Susan; Wender, Paul A; Fauci, Anthony S.
Affiliation
  • Blazkova J; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Infect Dis ; 206(5): 765-9, 2012 Sep 01.
Article in En | MEDLINE | ID: mdl-22732922
Persistence of the latent viral reservoir has been recognized as a major obstacle to eradicating human immunodeficiency virus (HIV) in infected individuals receiving antiretroviral therapy. It has been suggested that histone deacetylase inhibitors (HDACis) may purge HIV in the latent viral reservoir. However, the effect of HDACis on the degree and extent of HIV expression in the latent viral reservoir has not been fully delineated. Here we demonstrate that HDACis do not induce HIV production in the latent viral reservoir of aviremic individuals. Therefore, alternative therapeutic strategies may be necessary to eliminate HIV in the latent viral reservoir.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / HIV Infections / Valproic Acid / HIV-1 / Histone Deacetylase Inhibitors Limits: Humans Language: En Journal: J Infect Dis Year: 2012 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / HIV Infections / Valproic Acid / HIV-1 / Histone Deacetylase Inhibitors Limits: Humans Language: En Journal: J Infect Dis Year: 2012 Type: Article Affiliation country: United States